Uptake of core outcome sets by clinical trialists in China: a protocol
Open Access
- 28 March 2024
- journal article
- research article
- Published by F1000 Research Ltd in F1000Research
- Vol. 12, 1030
Abstract
Background The concept of core outcome sets (COS) has been introduced in China for about 10 years. In recent years, some Chinese researchers also committed to developing COS, though the majority of COS are ongoing. However, there were more than 500 published COS for research in the COMET database by 2020. The extent of availability of COS for the top 25 diseases with the highest burden in China is unknown. In addition, the uptake of COS in clinical trials for these diseases is unknown, along with the knowledge, perceptions, and views of the clinical trialist community in China on the use of COS in relation to choosing outcomes for their research. Methods The main burden of disease in China will be identified. Then we will search the COMET database to identify if there are ongoing or completed relevant COS research A COS published since 2012 would be preferred to one published before 2012 for the analysis of COS uptake if one meets the eligibility criteria. We will extract scopes of published eligible COS, including condition, population, interventions, and core outcomes. Then we will search the Chinese Clinical Trial Registry using disease names for each disease that has a published COS. We will assess the overlap in scope between clinical trials and COS. Then we will conduct an online survey and semi-structured interviews to identify the knowledge and perceptions of COS among primary investigators of included clinical trials. Discussion This research will fill in gaps between COS and the burden of disease in China. Understanding clinical trialists’knowledge and perceptions of COS may help dissemination and application of COS in the future. Trial registration This research is registered in Core Outcome Measures in Effectiveness: https://www.comet-initiative.org/Studies/Details/2563.Keywords
Funding Information
- National Natural Science Foundation of China (81904051)
- University of Liverpool
- National Institute for Health Research (NIHR) Senior Investigator award (NF-SI_0513-10025)
- MRC Trials Methodology Research Partnership (MR/S014357/1)
- Young Elite Scientists Sponsorship Program by CACM (CACM-2019-NRC2-A03)
- Qihuang Scholar of National Administration of Traditional Chinese Medicine (RS086)
This publication has 8 references indexed in Scilit:
- Patient participation impacts outcome domain selection in core outcome sets for research: an updated systematic reviewJournal of Clinical Epidemiology, 2023
- Review finds core outcome set uptake in new studies and systematic reviews needs improvementJournal of Clinical Epidemiology, 2022
- In-depth qualitative interviews identified barriers and facilitators that influenced chief investigators’ use of core outcome sets in randomised controlled trialsJournal of Clinical Epidemiology, 2022
- Use of core outcome sets was low in clinical trials published in major medical journalsJournal of Clinical Epidemiology, 2021
- More than half of systematic reviews have relevant core outcome setsJournal of Clinical Epidemiology, 2021
- Choosing important health outcomes for comparative effectiveness research: 6th annual update to a systematic review of core outcome sets for researchPLOS ONE, 2021
- Individual, health system, and contextual barriers and facilitators for the implementation of clinical practice guidelines: a systematic metareviewHealth Research Policy and Systems, 2020
- Clinical Research of Traditional Chinese Medicine Needs to Develop Its Own System of Core Outcome SetsEvidence-Based Complementary and Alternative Medicine, 2013